Cesca Therapeutics Inc (KOOL)

4.01
0.02 0.50
NASDAQ : Health Care
Prev Close 3.99
Open 3.98
Day Low/High 3.95 / 4.02
52 Wk Low/High 1.64 / 15.40
Volume 72.70K
Avg Volume 567.00K
Exchange NASDAQ
Shares Outstanding 9.79M
Market Cap 38.87M
EPS -7.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Cesca Therapeutics Granted Two Patents For Rapid Infusion Of Autologous Bone Marrow Derived Stem Cells

Cesca Therapeutics Granted Two Patents For Rapid Infusion Of Autologous Bone Marrow Derived Stem Cells

Technology Fundamental to Cesca's Proprietary SurgWerks™ Platform for CLI and AMI

Cesca Therapeutics (KOOL) Highlighted As Weak On High Volume

Cesca Therapeutics (KOOL) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Cesca Therapeutics (KOOL) as a weak on high relative volume candidate

Heavy Volume And Pre-Market Movement For Cesca Therapeutics (KOOL)

Heavy Volume And Pre-Market Movement For Cesca Therapeutics (KOOL)

Trade-Ideas LLC identified Cesca Therapeutics (KOOL) as a pre-market mover with heavy volume candidate

Cesca Therapeutics Announces Publication Of Results On Use Of Its Technology For Treatment Of Non-Union Fracture

Cesca Therapeutics Announces Publication Of Results On Use Of Its Technology For Treatment Of Non-Union Fracture

Data from Pilot Study Shows Promising Results for Bone Regeneration

7 Stocks Under $10 Making Big Moves

7 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Cesca Therapeutics To Exhibit At 14th International Cord Blood Symposium

Cesca Therapeutics To Exhibit At 14th International Cord Blood Symposium

World Leaders in Cord Blood Banking and Preservation Congregate at ICBS

Weak On High Volume: Cesca Therapeutics (KOOL)

Weak On High Volume: Cesca Therapeutics (KOOL)

Trade-Ideas LLC identified Cesca Therapeutics (KOOL) as a weak on high relative volume candidate

Cesca Therapeutics Reports Third Quarter Fiscal 2016 Results And Provides Business Update

Cesca Therapeutics Reports Third Quarter Fiscal 2016 Results And Provides Business Update

Management to Hold Conference Call Today at 2:00pm Pacific (5:00pm Eastern)

Cesca Therapeutics Announces 1-for-20 Reverse Split Of Common Stock

Cesca Therapeutics Announces 1-for-20 Reverse Split Of Common Stock

Trading on a Post-Split Basis is Scheduled to Begin March 7, 2016